Y Wen1, B C Deng, Y Zhou, Y Wang, W Cui, W Wang, P Liu. 1. Department of Infectious Diseases, The First Affiliated Hospital, China Medical University, Shenyang, China.
Abstract
BACKGROUND: Pneumonitis induced by pandemic influenza A H1N1 has a potential to cause respiratory failure, which is a risk factor for death. The underlying immunopathological mechanisms, however, have not yet been fully elucidated. PATIENTS AND METHODS: We investigated changes in plasma cytokines, T cell subsets, and C-reactive protein (CRP) in 16 hospitalized patients with pneumonia caused by 2009 H1N1 influenza infection. The patients were classified into a severe disease group and a mild disease group according to PaO2. RESULTS: Cytokine profiles showed no changes in interferon gamma (IFN-gamma), interleukin 6 (IL-6), IL-8, or transforming necrosis factor alpha (TNF-alpha) levels throughout the observation period. Transforming growth factor beta (TGF-beta1) was overproduced in the severe group but not in the mild group. Accordingly, we also found some signs of pulmonary fibrosis during the recovery period. Elevated CRP levels and lymphopenia were common in both the severe and the mild group. After treatment, there was a significant elevation in lymphocytes in both groups, but a significant decrease in CRP in the mild group. Lymphocyte counts and CRP levels rapidly recovered to normal levels in all survivors posttreatment; otherwise it seemed to be related to poor prognosis. CONCLUSIONS: Serial measurements of cytokines showed that only TGF-beta1 was overproduced, possibly in relation to the early use of corticosteroids, which may have downregulated immune responses to H1N1 infection. Pretreatment TGF-beta1 plasma concentrations and absolute lymphocyte counts were independent predictors of severity. However, the role of elevated TGF-beta1 in H1N1 infection-associated pulmonary fibrosis requires further investigation.
BACKGROUND:Pneumonitis induced by pandemic influenza A H1N1 has a potential to cause respiratory failure, which is a risk factor for death. The underlying immunopathological mechanisms, however, have not yet been fully elucidated. PATIENTS AND METHODS: We investigated changes in plasma cytokines, T cell subsets, and C-reactive protein (CRP) in 16 hospitalized patients with pneumonia caused by 2009 H1N1influenza infection. The patients were classified into a severe disease group and a mild disease group according to PaO2. RESULTS: Cytokine profiles showed no changes in interferon gamma (IFN-gamma), interleukin 6 (IL-6), IL-8, or transforming necrosis factor alpha (TNF-alpha) levels throughout the observation period. Transforming growth factor beta (TGF-beta1) was overproduced in the severe group but not in the mild group. Accordingly, we also found some signs of pulmonary fibrosis during the recovery period. Elevated CRP levels and lymphopenia were common in both the severe and the mild group. After treatment, there was a significant elevation in lymphocytes in both groups, but a significant decrease in CRP in the mild group. Lymphocyte counts and CRP levels rapidly recovered to normal levels in all survivors posttreatment; otherwise it seemed to be related to poor prognosis. CONCLUSIONS: Serial measurements of cytokines showed that only TGF-beta1 was overproduced, possibly in relation to the early use of corticosteroids, which may have downregulated immune responses to H1N1infection. Pretreatment TGF-beta1 plasma concentrations and absolute lymphocyte counts were independent predictors of severity. However, the role of elevated TGF-beta1 in H1N1infection-associated pulmonary fibrosis requires further investigation.
Authors: Erick J Rendón-Ramirez; Alejandro Ortiz-Stern; Corazon Martinez-Mejia; Mario C Salinas-Carmona; Adrian Rendon; Viviana L Mata-Tijerina; Adrian G Rosas-Taraco Journal: Viral Immunol Date: 2015-04-29 Impact factor: 2.257
Authors: Anniina Koski; Mari Raki; Petri Nokisalmi; Ilkka Liikanen; Lotta Kangasniemi; Timo Joensuu; Anna Kanerva; Sari Pesonen; Ramon Alemany; Akseli Hemminki Journal: Mol Ther Date: 2011-11-01 Impact factor: 11.454
Authors: Christine M Oshansky; Andrew J Gartland; Sook-San Wong; Trushar Jeevan; David Wang; Philippa L Roddam; Miguela A Caniza; Tomer Hertz; John P Devincenzo; Richard J Webby; Paul G Thomas Journal: Am J Respir Crit Care Med Date: 2014-02-15 Impact factor: 21.405